Macquarie Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History
Bought
Maintained
Sold
Other funds holding NBP
HA
CC
Macquarie Group's NBP Position: Q2 2022 in Review
Macquarie Group sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2022, closing a stake of 2,261 shares — an estimated $37 sold.
Macquarie Group first reported a position in NBP in Q2 2021 and held it in 4 quarters. The position peaked at $190K in Q2 2021. 97 funds tracked by Wall St. Rank hold NBP as of Q2 2022.
- Macquarie Group reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2022 after selling out during the quarter.
- Macquarie Group sold 2,261 NovaBridge Biosciences American Depositary Shares shares in Q2 2022, an estimated $37.
- Macquarie Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 4 quarters.
- Macquarie Group's NovaBridge Biosciences American Depositary Shares position peaked at $190K in Q2 2021.
- 97 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2022.
Based on Macquarie Group's 13F filing for Q2 2022, filed 15 Aug 2022.